Actavis (ACT) Reports In-Line Q4 EPS; Guides FY15 EPS, Revs

Actavis (NYSE: ACT) reported Q4 EPS of $3.91, in-line with the analyst estimate of $3.91. Revenue for the quarter came in at $4.01 billion versus the consensus estimate of $3.84 billion.

Actavis sees FY2015 EPS of $16.30-$17.30, versus the consensus of $16.63. Actavis sees FY2015 revenue of $15.0 billion, versus the consensus of $15.6 billion.

For earnings history and earnings-related data on Actavis (ACT) click here.

You May Also Be Interested In

• Constellation Brands (STZ) Tops Q1 EPS by 18c
• After-Hours Stock Movers: NKE, BE, STZ, RIG
• CareDx completes $171.2M sale of lab products unit to Eurobio Scientific